Fischer Medical Ventures

801.00
+36.60
(4.79%)
Market Cap
4,089.50 Cr
EPS
1.65
PE Ratio
-
Dividend Yield
0.00 %
Industry
Chemicals
52 Week High
798.00
52 Week low
397.30
PB Ratio
50.75
Debt to Equity
0.03
Add Ratio

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
846.05 21,774.00 49.15 15,707.00 -7.64 449 -110.82 27.29
1,069.60 13,448.10 15.44 8,798.90 -22.71 457 318.35 46.30
543.65 8,098.60 15.69 8,398.90 -20.68 485 68.04 43.28
417.75 6,498.30 - 4,003.40 -20.27 -158 45.41 37.74
604.40 5,881.30 9.83 3,498.80 -23.68 794 68.74 33.25
579.30 4,274.50 - 3,896.70 -14.52 -237 90.27 22.21
89.90 4,131.90 25.74 1,099.90 9.90 146 0.70 40.73
801.00 4,089.50 - 21.50 10,650.00 2 62.50 76.18
3,566.45 3,393.90 43.46 385.20 0.60 53 244.55 57.64
230.07 2,405.80 - 2,102.50 -2.77 -39 -82.61 36.62
Growth Rate
Revenue Growth
10,650.00 %
Net Income Growth
5,135.34 %
Cash Flow Change
-165.49 %
ROE
-83.45 %
ROCE
-46.88 %
EBITDA Margin (Avg.)
29.78 %

Quarterly Financial Results

Quarterly Financials
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Revenue
0
0
0
21
11
40
12
Expenses
0
0
1
18
10
39
11
EBITDA
0
0
-1
3
1
1
1
Operating Profit %
0 %
0 %
-347 %
12 %
-3 %
1 %
3 %
Depreciation
0
0
0
0
0
0
1
Interest
0
0
0
0
0
0
0
Profit Before Tax
0
0
-1
3
0
0
0
Tax
0
0
0
0
0
-0
0
Net Profit
0
0
-1
3
-0
0
-0
EPS in ₹
0.00
0.00
0.00
0.48
-0.02
0.05
-0.05

Balance Sheet

Balance Sheet
2023
2024
Total Assets
0
86
Fixed Assets
0
15
Current Assets
0
70
Capital Work in Progress
0
0
Investments
0
1
Other Assets
0
70
Total Liabilities
0
86
Current Liabilities
0
4
Non Current Liabilities
1
1
Total Equity
-0
81
Reserve & Surplus
-0
27
Share Capital
0
54

Cash Flow

Cash Flow
2024
Net Cash Flow
1
Investing Activities
-29
Operating Activities
-8
Financing Activities
37

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Jan 2024
Mar 2024
May 2024
Jun 2024
Sept 2024
Dec 2024
Promoter
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
74.91 %
74.91 %
74.91 %
74.91 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
5.07 %
5.07 %
5.07 %
5.07 %
5.07 %
DIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
1.68 %
1.68 %
1.68 %
1.68 %
1.68 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
96.72 %
96.72 %
96.61 %
94.42 %
94.38 %
94.43 %
94.43 %
94.23 %
94.20 %
99.60 %
97.60 %
97.59 %
29.75 %
29.37 %
16.47 %
16.48 %
16.39 %
16.37 %
Others
3.28 %
3.28 %
3.39 %
5.58 %
5.62 %
5.57 %
5.57 %
5.77 %
5.80 %
0.40 %
2.40 %
2.41 %
70.25 %
63.88 %
1.87 %
1.86 %
1.94 %
1.96 %
No of Share Holders
9,046
9,043
9,085
9,109
9,093
9,121
9,121
9,064
9,060
9,085
9,104
9,038
9,065
8,976
8,975
9,285
9,502
9,688

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Annual Cash Flows 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Dividend Per Share (₹) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Corporate Action

Announcements

Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011
11 hours ago
Update On Receipt Of Disclosure Under Regulation 29(2) Of SEBI (SAST) 2015
2 days ago
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011
3 days ago
Board Meeting Outcome for Allotment Of Equity Shares And Warrants
3 days ago
Announcement Under Regulation 30 - Incorporation Of Subsidiary Company
6 days ago
Board Meeting Outcome for RESULTS - FINANCIAL RESULTS - 31.12.2024
7 days ago
Results - Financial Results For 31/12/2024
7 days ago
Update From Material Subsidiary
7 days ago
Announcement Under Regulation 30 - Update On Re- Constitution Of Audit Committee
8 days ago
Board Meeting Intimation for Consideration And Approval Of Unaudited Financial Results For The Quarter Ended 31.12.2024
Feb 07, 2025, 18:02
Intimation Of Supply Of 10 Nos. Of 1.5T Whole Body MRI Machines To Atrium Diagnostics
Feb 05, 2025, 10:59
Shareholder Meeting / Postal Ballot-Scrutinizer"s Report
Feb 02, 2025, 15:24
Announcement under Regulation 30 (LODR)-Meeting Updates
Feb 02, 2025, 15:19
Announcement under Regulation 30 (LODR)-Meeting Updates
Jan 31, 2025, 16:03
Proceedings Of Extra Ordinary General Meeting Dated 31.01.2025
Jan 31, 2025, 15:55
Intimation Of Development Of Advanced AI Powered Healthcare Solutions By Wholly Owned Subsidiary Of The Company
Jan 27, 2025, 11:45
Intimation Of Launch Of Sikkim MRI Public - Private Partnership (PPP) Project
Jan 20, 2025, 13:28
Intimation Of License To Manufacture MRI By CDSCO To The Material Subsidiary Of The Company
Jan 14, 2025, 12:14
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
Jan 13, 2025, 18:08
Announcement under Regulation 30 (LODR)-Newspaper Publication
Jan 10, 2025, 21:34
Shareholders Meeting - EGM On 31/01/2025
Jan 09, 2025, 20:44
Announcement under Regulation 30 (LODR)-Meeting Updates
Jan 03, 2025, 18:26
Board Meeting Outcome for Outcome Of Board Meeting Is Enclosed Herewith
Jan 03, 2025, 18:18
Closure of Trading Window
Dec 31, 2024, 18:05
Announcement under Regulation 30 (LODR)-Investor Presentation
Dec 28, 2024, 19:26
Announcement Under Regulation 30- Update On Upcoming Board Meeting
Dec 28, 2024, 13:44
Board Meeting Intimation for To Consider Approve Business Items Relating To Preferential Issue And Other Business Item
Dec 28, 2024, 13:16

Technical Indicators

RSI(14)
Neutral
69.35
ATR(14)
Volatile
35.26
STOCH(9,6)
Neutral
65.46
STOCH RSI(14)
Overbought
100.00
MACD(12,26)
Bullish
5.63
ADX(14)
Weak Trend
18.32
UO(9)
Bearish
40.69
ROC(12)
Uptrend But Slowing Down
7.98
WillR(14)
Neutral
-44.99